BBIO
BridgeBio Pharma, Inc.NASDAQStock$74.64+1.35 (+1.85%)Mkt Cap 14.5BP/E —Div Yield —Beta 1.09Vol 2.5MAvg Vol 2.0M
52W$32.26
$79.91
ETFs That Hold BBIO (BridgeBio Pharma, Inc.)
1M
+7.44%
3M
-3.83%
6M
+17.60%
YTD
-4.75%
1Y
+107.63%
3Y
+419.67%
5Y
+34.83%
ETFs That Hold BBIO
BridgeBio Pharma, Inc. is held by 110 ETFs. The largest position by market value is in VTI (Vanguard Total Stock Market ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.30% |
| JHML | John Hancock Investments - Multifactor Large Cap ETF | 0.01% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.11% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.07% |
| STXG | Strive 1000 Growth ETF | 0.03% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.20% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 0.71% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.24% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.18% |
| WDNA | WisdomTree BioRevolution Fund | 0.55% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.36% |
| HDG | ProShares - Hedge Replication ETF | 0.06% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.13% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.01% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.01% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.01% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold BBIO?
BridgeBio Pharma, Inc. (BBIO) is held by 110 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VTI (Vanguard Total Stock Market ETF).
What is the largest ETF that holds BBIO?
By fund size, VTI (Vanguard Total Stock Market ETF) with $2.00T in AUM holds 0.02% of its portfolio in BBIO, representing $420.7M in market value.
What percentage of HELX is BBIO?
BBIO makes up 4.02% of HELX (Franklin Genomic Advancements ETF), making it one of the largest positions in that fund.
Is BBIO in the S&P 500?
BBIO is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.